secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001753926-25-000604
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella increases designated Series C preferred shares from 1,050,000 to 1,260,000
--------------------------------------------------------------------------------

- Filed Certificate of Amendment on April 8, 2025, increasing Series C Voting Convertible Preferred Stock designation from 1,050,000 to 1,260,000 shares.
- Amendment modifies existing Certificate of Designation, potentially altering voting or conversion rights of current holders.
- Change in authorized shares may indicate future financing or strategic moves by the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625000604/0001753926-25-000604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625000604/g084766_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer